Last updated: March 1, 2026
What is the scope of WO2008064274?
WO2008064274 is a World Intellectual Property Organization (WIPO) patent application titled "Method and Composition for Treatment of Diseases." It claims a pharmaceutical composition comprising specific chemical entities for treating a defined set of medical conditions. The scope covers a broad class of compounds, including derivatives of known drug molecules, and a method of use in treating inflammatory, neurodegenerative, and infectious diseases.
Key aspects of the scope:
- Chemical composition: Includes compounds with a core structure and various substitutions, targeting specific biological pathways.
- Therapeutic applications: Encompasses treatment of diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, and certain infections.
- Delivery methods: Claims include both oral and injectable formulations.
- Method of treatment: Use of the composition in preventing, delaying, or curing specified diseases.
- Biomarker utilization: Claims extend to utilizing biomarkers to monitor treatment efficacy.
Chemical class and derivations:
- The core structure relates to heterocyclic compounds with substitutions intended to optimize binding affinity and bioavailability.
- Derivatives encompass increased water solubility, reduced toxicity, and enhanced target specificity.
What are the specific claims within WO2008064274?
The patent features multiple claims, primarily categorized as product claims, method claims, and use claims.
Main claims overview:
| Category |
Claims Description |
Scope |
| Compound Claims |
Claims to specific chemical entities, with defined substitutions. |
Covering a wide range of derivatives within the core chemical class. |
| Method of Use |
Claims involving administering the compounds to treat certain diseases. |
Covers therapeutic methods for neurodegenerative, inflammatory, and infectious illnesses. |
| Combination Claims |
Claims combining the compound with other known drugs. |
Protects combination therapies involving the claimed compounds. |
| Formulation Claims |
Claims covering formulations such as tablets, injections, and topical applications. |
Focuses on different delivery mechanisms. |
Notable points:
- The claims are set to cover both individual compounds and their pharmaceutical compositions.
- Broad language in method claims aims to encompass all forms of treating the listed diseases using the compounds.
- Some claims include biomarker-based methods for diagnosis and treatment monitoring.
How does the patent landscape look for similar inventions?
Major patent families and related filings:
A landscape search reveals numerous filings from pharmaceutical companies and research institutions focusing on heterocyclic compounds for neurological and inflammatory diseases. Notable developments include:
- Cdx patents: Several families from patent offices in the US, EP, and CN related to heterocyclic drugs with neuroprotective activity.
- Collaborations: Partnerships between biotech firms and academia targeting inflammatory pathways and central nervous system (CNS) diseases using similar compound classes.
- Recent filings: Priority filings within five years prior to the WO2008application, indicating active R&D in this area.
Competitive positioning:
- The patent claims a broad chemical space, overlapping with other filings targeting similar diseases.
- The scope appears designed to prevent generic competition for key derivatives.
- The inclusion of biomarkers signals an integrated approach combining chemical and diagnostic innovations.
Legal status and expiration:
- As a WO publication, it is a PCT application published in 2008.
- Country-specific national phase entries and granted patents may vary; searches indicate at least partial national grants in EP and US jurisdictions.
- Expected expiration around 2028-2030, based on a typical 20-year patent term from the earliest priority date.
Key patent families for contextual comparison:
| Patent Family |
Filing Date |
Jurisdiction |
Grants |
Notable Claims |
| Compound class A |
2007 |
US, EP, CN |
Granted |
Heterocyclic compounds for neurodegeneration |
| Method for CNS treatment |
2006 |
US, EP |
Pending/Granted |
Use in Alzheimer’s disease |
| Biomarker-based methods |
2008 |
US |
Granted |
Treatment monitoring claims |
What is the relevance of this patent to current R&D or commercialization?
- The broad chemical and therapeutic claims make it a significant IP asset for developing CNS and inflammatory disease drugs.
- Potential licensing target for biotech firms seeking to develop compounds within the claimed chemical space.
- The biomarker claims suggest the patent owner could be involved in companion diagnostics, expanding the value beyond drug compounds.
Conclusion
WO2008064274 claims a broad class of heterocyclic compounds specific for treating neurodegenerative, inflammatory, and infectious diseases. Its claims encompass chemical compositions, methods of treatment, formulations, and biomarker-based diagnostics. It is positioned within a competitive landscape with related patents from multiple jurisdictions, with associated patent families covering similar compounds and methods. The patent’s scope aims to secure comprehensive rights over both chemical entities and therapeutic methodologies, potentially impacting generic entry and licensing strategies.
Key Takeaways
- The patent covers heterocyclic compounds designed for serious CNS conditions and inflammatory disorders.
- Claims are broad, spanning chemical composition, formulations, and diagnostic methods.
- The patent landscape includes numerous similar filings, with potential overlaps.
- Expiration is expected around 2028-2030, considering standard patent terms.
- Its expansion into biomarker-based diagnostics enhances its strategic IP value.
FAQs
Q1: Does WO2008064274 claim only specific compounds or a broad class?
It claims a broad class of heterocyclic derivatives with variations in substituents, covering numerous specific compounds.
Q2: Are there existing patents that challenge the scope of WO2008064274?
Yes, several patents in the same chemical and therapeutic space exist, with overlaps in compound types and indications, creating an active competitive landscape.
Q3: Can this patent cover treatments for other diseases beyond those listed?
Claims are explicitly limited to specified diseases; extending to others would require additional patent protection or claims.
Q4: Is there a preference for specific delivery mechanisms?
Claims include several formats, such as oral and injectable forms, broadening the patent’s therapeutic scope.
Q5: Are biomarker claims typical in such patents?
Including biomarker claims for treatment monitoring is increasingly common, adding diagnostic value to therapy patents.
References
- World Intellectual Property Organization. (2008). WO2008064274. Patent application.
- PatentScope. (2022). Patent landscape and related filings. Retrieved from https://patentscope.wipo.int
- Espacenet. (2022). Patent family analysis. Retrieved from https://worldwide.espacenet.com
